{"id":"W1593394252","doi":"10.4161/hv.27813","title":"Antibody therapy for Ebola","year":2014,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Ebola virus; Medicine; Virology; Ebola Hemorrhagic Fever; Infectious disease (medical specialty); Immunology; Viral hemorrhagic fever; Ebolavirus; Ebola vaccine; Biosafety; Monoclonal antibody; Disease; Antibody; Immunization; Virus; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007560008,0.0003476552,0.0003483888,0.0006881344,0.0004139496,0.0005304767,0.0003921984,0.001110162,0.007150835],"category_scores_gemma":[0.0006312489,0.00009369486,0.0004204714,0.0002957216,0.0003419862,0.0006494014,0.0005338098,0.002124684,0.002778588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000487442,"about_ca_system_score_gemma":0.0003553981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004830447,"about_ca_topic_score_gemma":0.0007641456,"domain_scores_codex":[0.9997593,0.00007901432,0.0000143763,0.00002984398,0.00007818782,0.00003931365],"domain_scores_gemma":[0.9998776,0.00003484792,0.00001907044,0.00001092107,0.0000341478,0.00002347786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009311585,0.0009362111,0.0007707941,0.001734032,0.0001529221,0.0006999722,0.0001940212,0.0005174472,0.06242547,0.02263137,0.08574327,0.8232632],"study_design_scores_gemma":[0.0004050797,0.001811773,0.001163917,0.0004158492,0.00008087169,0.00243465,0.00003843943,0.000494648,0.01718147,0.005121835,0.9708326,0.00001889321],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03972597,0.8011462,0.02821221,0.02671587,0.007718961,0.0004732588,0.0005563024,0.0006170968,0.09483408],"genre_scores_gemma":[0.3315008,0.534493,0.0233228,0.02760647,0.004509877,0.000891555,0.001503989,0.0001372416,0.07603423],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007150835,"threshold_uncertainty_score":0.02392191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04989509989569584,"score_gpt":0.4004329533478755,"score_spread":0.3505378534521796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}